Primary Care Diabetes
Volume 1, Issue 2 , Pages 75-80 , June 2007

Diagnosed diabetic retinopathy in France, Italy, Spain, and the United Kingdom

  • A. Rubino

      Affiliations

    • RTI Health Solutions, Manchester Science Park, Manchester, UK
    • ,
  • M.D. Rousculp

      Affiliations

    • Eli Lilly and Company, Indianapolis, IN, USA
    • ,
  • K. Davis

      Affiliations

    • RTI Health Solutions, Research Triangle Park, NC, USA
    • Corresponding Author InformationCorresponding author at: RTI Health Solutions, P.O. Box 12194, 3040 Cornwallis Road, Research Triangle Park, NC 27709-2194, USA. Tel.: +1 919 541 6762; fax: +1 919 485 7222.
    • ,
  • J. Wang

      Affiliations

    • RTI Health Solutions, Research Triangle Park, NC, USA
    • ,
  • A. Girach

      Affiliations

    • Eli Lilly and Company Research Laboratories, Erl Wood, Windlesham, Surrey, UK

Received 8 February 2007 ,Accepted 19 February 2007.

References 

  1. Engerman RL. Pathogenesis of diabetic retinopathy. Diabetes. 1989;38:1203–1206
  2. Lopes de Faria JM, Jalkh AE, Trempe CL, McMeel JW. Diabetic macular edema: risk factors and concomitants. Acta Ophthalmol. Scand. 1999;77:170–175
  3. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, et al. Diabetic retinopathy. Diabetes Care. 1998;21:143–156
  4. Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening and novel therapies. Diabetes Care. 2003;26(9):2653–2664
  5. Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology. 1984;91:1–9
  6. World Health Organization (WHO) Diabetes Mellitus Fact Sheet. Available at: http://www.who.int/mediacentre/factsheets/fs138/en/ (last accessed: June 2006).
  7. Foster A, Resnikoff S. The impact of Vision 2020 on global blindness. Eye. 2005;19:1133–1135
  8. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, et al. Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes. 1990;39:1111–1124
  9. Jerneld B. Prevalence of diabetic retinopathy. A population study from the Swedish island of Gotland. Acta Ophthalmol. 1988;88:3–32
  10. Ballone E, Colagrande V, Nicola M, Di Mascio R, Di Mascio C, Capani F. Probabilistic approach to developing nephropathy in patients with retinopathy. Statistics in Medicine. 2003;22:3889–3897
  11. van Hecke MV, Dekker JM, Stehouwer CD, Polak BC, Fuller JH, Sjolie AK, et al. EURODIAB prospective complications study. Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study. Diabetes Care. 2005;28(6):1383–1389
  12. AMD 2002 Screening, diagnostic e trattament o della retinopatia diabetica in Italia, Linee guida elaborate da AMD, ANAO-ASSOMED, Consorzio Mario Negri Sud, FAND-AID, FIMMG, Gruppo di studio complicanze oculari della SID, SID, SIR, SOI-APIMO-AMOI e Tribunale dei diritti del malato. Accessible at: http://www.siditalia.it/Pubblicazioni/lineeguida_rd.pdf (last accessed: June 2006).
  13. NICE, Diabetic retinopathy: early management and screening, 2002. Available at: http://www.nice.org.uk/page.aspx?o=28677 (last accessed: June 2006).
  14. ANAES, Recommandations pour la pratique clinique: Suivi du patient diabétique de type 2 à l’exclusion du suivi des complications. Available at: http://www.anaes.fr/ANAES/anaesparametrage.nsf/Page?ReadForm&Section=/anaes/SiteWeb.nsf/wRubriquesID/APEH-3YTFUH?OpenDocument&Defaut=y& (accessed: June 2006).
  15. Weill A, Ricordeau P, Vallier N, Bourrel R, Fender P, Allemand H. Modalities of follow-up on non-insulin treated diabetics treated in metropolitan France in 1998. Diabetes Metab. 2000;26(Suppl. 6):39–48
  16. Deb N, Thuret G, Estour B, Massin P, Gain P. Screening for diabetic retinopathy in France. Diabetes Metab. 2004;30:140–145
  17. Anton Sanz MC, Saiz Careaga MT, Tormos Perez I, Perez-Torregrosa VT, Sanchez Calso A. Assessment of ophthalmologic control of the diabetic patient in primary care. Aten. Primaria. 2000;26:30–34
  18. Nicolucci A, Scorpiglione N, Belfiglio M, Carinci F, Cavaliere D, el-Shazly M, et al. Patterns of care an Italian diabetic population. The Italian Study Group for the Implementation of the St Vincent Declaration, Societa’ Italiana di Diabetologia, Associazione Medici Diabetologi. Diabet. Med. 1997;14:158–166
  19. American Academy of Ophthalmology (AAO) Retina Panel, Preferred Practice Pattern: Diabetic Retinopathy, American Academy of Ophthalmology, San Francisco, CA, 2003. Available through: http://www.aao.org/education/library/ppp/index.cfm (accessed: January 5, 2005).
  20. Le Floch JP, Thervet F, Descriac I, Boyer JF, Simon D The Practitioners of the French Observatory of Diabetes Mellitus. Management of diabetic patients by general practitioners in France 1997: an epidemiological study. Diabetes Metab. 2000;26:43–49
  21. Delcourt C, Vauzelle-Kervroedan F, Cathelineau G, Papoz L The CODIAB-INSERM-ZENECA Pharma Study Group. Low prevalence of long-term complications in non-insulin dependent diabetes mellitus in France: a multicenter study. J. Diabetes Complications. 1998;12:88–95
  22. Zafra Mezcua JA, Mendez Segovia JC, Novalbos Ruiz JP, Costa Alonso MJ, Failde Martinez I. Chronic complications in patients with type 2 diabetes mellitus cares for at a health center. Aten. Primaria. 2000;25:529–535
  23. Romero Aroca P, Calvino Dominguez O, Del Castillo Dejardin D. Epidemiologic study of diabetic retinopathy in a primary care unit. Arch. Soc. Esp. Oftalmol. 2000;75:147–152
  24. Morgan C, Currie C, Stott N, Smithers M, Butler C, Peters J. The prevalence of multiple diabetes-related complications. Diabet. Med. 2000;17:146–151
  25. Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, Matthews DR, et al. United Kingdom Prospective Diabetes Study 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch. Ophthalmol. 1998;116:297–303
  26. Broadbent DM, Scott JA, Vora JP, Harding SP. Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study. Eye. 1999;13(April (Pt 2)):160–165
  27. Ling R, Ramsewak V, Taylor D, Jacob J. Longitudinal study of a cohort of people with diabetes screened by the Exeter Diabetic Retinopathy Screening Programme. Eye. 2002;16:140–145
  28. Segato T, Midena E, Grigoletto F, Zucchetto M, Fedele D, Piermarocchi S, et al. The epidemiology and prevalence of diabetic retinopathy in the Veneto region of northeast Italy. Veneto Group for Diabetic Retinopathy. Diabet. Med. 1991;8:Spec No S11–S16

PII: S1751-9918(07)00033-2

doi: 10.1016/j.pcd.2007.02.002

Primary Care Diabetes
Volume 1, Issue 2 , Pages 75-80 , June 2007

Article Tools

* Image Usage & Resolution